Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy

P. Murino, M. Mammucari, D. Borrelli, A. Pepe, M. F. Giugliano, A. Morra, G. Panelli, R. Manzo, V. Ravo, P. Muto

Research output: Contribution to journalArticle

Abstract

Radiotherapy is crucial in the management of cancer patients in both the curative and palliative settings. However, patients often report pain both during positioning for, and execution of, radiotherapy and this may be a reason for interrupting the radiotherapy session. This observation is common even if the patient is undergoing baseline drug therapy for cancer pain. Recent data suggest that orally administrated immediate-release morphine (MIR) is able to reduce pain in patients with predictable pain. The authors tested a rescue dose of MIR 10 or 20 mg, 20 to 60 minutes before radiotherapy, to verify the effectiveness of MIR in this setting and also to assess the patient's ability to receive the full course of radiotherapy. One hundred forty consecutive patients were evaluated during radiotherapy treatment and visual analogue scale (VAS) and positioning VAS scores were assessed. All patients completed the course of scheduled radiotherapy and pain was well controlled, despite the fact that previous pharmacological treatment had not been able to completely control chronic cancer pain. These data strongly suggest a role for MIR pretreatment in patients with pain due to positioning during radiotherapy.

Original languageEnglish
Pages (from-to)121-124
Number of pages4
JournalJournal of Pain and Palliative Care Pharmacotherapy
Volume25
Issue number2
DOIs
Publication statusPublished - Jun 7 2011

Fingerprint

Morphine
Radiotherapy
Pain
Therapeutics
Visual Analog Scale
Aptitude
Chronic Pain
Pharmacology
Drug Therapy
Neoplasms

Keywords

  • immediate-release morphine
  • predictable pain
  • radiotherapy

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)

Cite this

Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy. / Murino, P.; Mammucari, M.; Borrelli, D.; Pepe, A.; Giugliano, M. F.; Morra, A.; Panelli, G.; Manzo, R.; Ravo, V.; Muto, P.

In: Journal of Pain and Palliative Care Pharmacotherapy, Vol. 25, No. 2, 07.06.2011, p. 121-124.

Research output: Contribution to journalArticle

Murino, P. ; Mammucari, M. ; Borrelli, D. ; Pepe, A. ; Giugliano, M. F. ; Morra, A. ; Panelli, G. ; Manzo, R. ; Ravo, V. ; Muto, P. / Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy. In: Journal of Pain and Palliative Care Pharmacotherapy. 2011 ; Vol. 25, No. 2. pp. 121-124.
@article{952e8a99ef624196ab6657b0808b3b8d,
title = "Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy",
abstract = "Radiotherapy is crucial in the management of cancer patients in both the curative and palliative settings. However, patients often report pain both during positioning for, and execution of, radiotherapy and this may be a reason for interrupting the radiotherapy session. This observation is common even if the patient is undergoing baseline drug therapy for cancer pain. Recent data suggest that orally administrated immediate-release morphine (MIR) is able to reduce pain in patients with predictable pain. The authors tested a rescue dose of MIR 10 or 20 mg, 20 to 60 minutes before radiotherapy, to verify the effectiveness of MIR in this setting and also to assess the patient's ability to receive the full course of radiotherapy. One hundred forty consecutive patients were evaluated during radiotherapy treatment and visual analogue scale (VAS) and positioning VAS scores were assessed. All patients completed the course of scheduled radiotherapy and pain was well controlled, despite the fact that previous pharmacological treatment had not been able to completely control chronic cancer pain. These data strongly suggest a role for MIR pretreatment in patients with pain due to positioning during radiotherapy.",
keywords = "immediate-release morphine, predictable pain, radiotherapy",
author = "P. Murino and M. Mammucari and D. Borrelli and A. Pepe and Giugliano, {M. F.} and A. Morra and G. Panelli and R. Manzo and V. Ravo and P. Muto",
year = "2011",
month = "6",
day = "7",
doi = "10.3109/15360288.2011.554488",
language = "English",
volume = "25",
pages = "121--124",
journal = "Journal of Pain and Palliative Care Pharmacotherapy",
issn = "1536-0288",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Role of immediate-release morphine (MIR) in the treatment of predictable pain in radiotherapy

AU - Murino, P.

AU - Mammucari, M.

AU - Borrelli, D.

AU - Pepe, A.

AU - Giugliano, M. F.

AU - Morra, A.

AU - Panelli, G.

AU - Manzo, R.

AU - Ravo, V.

AU - Muto, P.

PY - 2011/6/7

Y1 - 2011/6/7

N2 - Radiotherapy is crucial in the management of cancer patients in both the curative and palliative settings. However, patients often report pain both during positioning for, and execution of, radiotherapy and this may be a reason for interrupting the radiotherapy session. This observation is common even if the patient is undergoing baseline drug therapy for cancer pain. Recent data suggest that orally administrated immediate-release morphine (MIR) is able to reduce pain in patients with predictable pain. The authors tested a rescue dose of MIR 10 or 20 mg, 20 to 60 minutes before radiotherapy, to verify the effectiveness of MIR in this setting and also to assess the patient's ability to receive the full course of radiotherapy. One hundred forty consecutive patients were evaluated during radiotherapy treatment and visual analogue scale (VAS) and positioning VAS scores were assessed. All patients completed the course of scheduled radiotherapy and pain was well controlled, despite the fact that previous pharmacological treatment had not been able to completely control chronic cancer pain. These data strongly suggest a role for MIR pretreatment in patients with pain due to positioning during radiotherapy.

AB - Radiotherapy is crucial in the management of cancer patients in both the curative and palliative settings. However, patients often report pain both during positioning for, and execution of, radiotherapy and this may be a reason for interrupting the radiotherapy session. This observation is common even if the patient is undergoing baseline drug therapy for cancer pain. Recent data suggest that orally administrated immediate-release morphine (MIR) is able to reduce pain in patients with predictable pain. The authors tested a rescue dose of MIR 10 or 20 mg, 20 to 60 minutes before radiotherapy, to verify the effectiveness of MIR in this setting and also to assess the patient's ability to receive the full course of radiotherapy. One hundred forty consecutive patients were evaluated during radiotherapy treatment and visual analogue scale (VAS) and positioning VAS scores were assessed. All patients completed the course of scheduled radiotherapy and pain was well controlled, despite the fact that previous pharmacological treatment had not been able to completely control chronic cancer pain. These data strongly suggest a role for MIR pretreatment in patients with pain due to positioning during radiotherapy.

KW - immediate-release morphine

KW - predictable pain

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=79958290912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958290912&partnerID=8YFLogxK

U2 - 10.3109/15360288.2011.554488

DO - 10.3109/15360288.2011.554488

M3 - Article

C2 - 21657859

AN - SCOPUS:79958290912

VL - 25

SP - 121

EP - 124

JO - Journal of Pain and Palliative Care Pharmacotherapy

JF - Journal of Pain and Palliative Care Pharmacotherapy

SN - 1536-0288

IS - 2

ER -